Tissue-Link ApS: Financial statements 2022
CVR: 40633979
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Tissue-Link ApS (CVR 40633979) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -230,803 and a net result of DKK -183,865 compared with DKK 326,453 the year before. Equity in the 2022 report amounted to DKK 231,410. The solvency ratio was 93.7%.
- Gross Profit
- DKK -230,803
- Profit/Loss
- DKK -183,865
- Equity
- DKK 231,410
- Total Assets
- DKK 247,058
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -231 t. | -184 t. | 231 t. | - |
| 2021 | - | 367 t. | 326 t. | 415 t. | - |
| 2020 | - | -214 t. | -189 t. | 89 t. | 0 |
Official annual report
Keep an eye on Tissue-Link ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Tissue-Link ApS has published its annual report for 2021. Gross profit came to DKK 366,795, and the net result was DKK 326,453.
About Tissue-Link ApS
Tissue-Link ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Aadal Nielsen. The board consists of Charlotte Videbæk (chair), Niels Ole Mikkelsen and Peter Aadal Nielsen. The company's owners include Kurt Bækgaard Osther, AADALBIOTECH ApS and LGM WINTHER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -818,426 and a net result of DKK -771,522 compared with DKK -319,133 the year before. Equity in the 2025 report amounted to DKK -853,415.